Position in JNJ
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$3,050,687
-$3,716,634 QoQ
Shares Held
12,012
-56.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#1,995
of 4,664 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Allen Capital Group, LLC holds $17,687,025 across 8 Drug Manufacturers - General names. JNJ ranks #3 (17.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
218,728 | $5,266,970 | |
| 2 | NVO |
Novo Nordisk A S
|
76,530 | $3,668,848 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
12,012 | $3,050,687 | |
| 4 | LLY |
ELI LILLY & Co
|
2,102 | $2,521,202 | |
| 5 | MRK |
Merck & Co., Inc.
|
10,589 | $1,360,686 | |
| 6 | ABBV |
AbbVie Inc.
|
3,915 | $985,170 | |
| 7 | AMGN |
Amgen Inc
|
1,428 | $517,107 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,504 | $316,355 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,050,687 | 12,012 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $6,767,321 | 27,685 | Shares | Sole | 2026-05-27 | |
| 2025-12-31 | $5,470,102 | 26,432 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $4,787,544 | 25,820 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $3,666,611 | 24,004 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,798,233 | 22,903 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $2,893,846 | 20,010 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $3,334,060 | 20,573 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,833,019 | 19,383 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,568,766 | 22,560 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $3,490,599 | 22,270 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $3,561,691 | 22,868 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $3,580,694 | 21,633 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $3,362,260 | 21,692 | Shares | Sole | 2023-04-28 | |
| 2022-09-30 | $3,164,773 | 19,373 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $3,430,025 | 19,323 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $4,369,073 | 24,652 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $4,277,263 | 25,003 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $4,035,077 | 24,985 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $4,066,277 | 24,683 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $3,427,847 | 20,857 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $3,075,205 | 19,540 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $2,717,208 | 18,251 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $2,545,965 | 18,104 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $2,311,035 | 17,624 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||